Anti-snoring Treatment Market Analysis
In the market, devices are categorized into mandible advancement devices, tongue stabilizing devices, nasal devices, continuous positive airway pressure (CPAP) devices, chin straps, and other devices. The CPAP devices segment led the market with a revenue of USD 426.3 million in 2024 and is expected to grow at a significant CAGR during the forecast period.
- CPAP devices are the standard treatment for obstructive sleep apnea (OSA) and snoring. With the increasing prevalence of these conditions, the adoption of CPAP devices is expected to rise, driving market growth. According to the National Council on Aging, nearly 39 million adults in the U.S. currently suffer from obstructive sleep apnea. CPAP devices effectively treat moderate to severe sleep apnea, contributing to their market growth.
- CPAP therapy keeps airways open by delivering a continuous stream of air through a mask worn during sleep. These devices improve airway function, promote restful sleep, and increase consumer preference for this technology. The continuous airflow helps users achieve better sleep, enhancing the appeal of CPAP devices.
- Rising awareness of sleep disorders and the proven effectiveness of CPAP therapy are expected to drive segment growth in the coming years. As more people understand the importance of treating sleep apnea and related conditions, the demand for CPAP devices is likely to grow, supporting the market's expansion.
Based on distribution channel, the anti-snoring treatment market is segmented into hospitals, clinics, retail pharmacies, e-commerce, and other distribution channels. The e-commerce segment dominated the market in 2024 and is expected to grow significantly to reach USD 1.1 billion by 2034.
- The growing trend in product purchases through online channels, increasing internet penetration, and easy access to a broad range of anti-snoring devices and products that can be ordered from home have led to the dominance of e-commerce as a distribution channel for anti-snoring devices. This is especially important for people who may be uncomfortable discussing snoring issues in person due to social stigma.
- Moreover, online platforms often offer a greater variety of anti-snoring solutions than retail pharmacies or clinics, including specialized devices like chin straps, CPAP masks, and nasal dilators. This variety allows consumers to find specific products tailored to their needs.
In 2024, the U.S. led the North American anti-snoring treatment market, generating USD 559 million, and is expected to see significant growth during the forecast period.
- In the U.S., growing awareness about sleep disorders and their health impacts is driving the market. As Americans increasingly recognize the importance of quality sleep for overall health, the demand for effective snoring solutions is rising. This trend is further supported by increasing obesity rates—a major risk factor for snoring—and an aging population more prone to sleep-related issues.
- Technological advancements have expanded the market by introducing non-invasive and user-friendly anti-snoring devices and treatments. These innovations appeal to consumers seeking alternatives to traditional, often invasive, snoring remedies.
- Broader healthcare coverage for sleep-related treatments has also made anti-snoring solutions more accessible. For example, Medicare covers CPAP devices for treating Obstructive Sleep Apnea (OSA).
- These factors have created a favorable environment for the U.S. market. As healthcare providers and consumers prioritize sleep health, the demand for effective snoring solutions continues to grow. This trend is expected to persist, supported by ongoing research, technological advancements, and a focus on preventive healthcare.
From 2025 to 2034, France's anti-snoring treatment market is expected to grow significantly.
- In France, increasing awareness and improved diagnosis of sleep disorders, especially obstructive sleep apnea (OSA), are driving market growth. As more people seek medical help for snoring and related conditions, the demand for solutions like CPAP devices and mandibular advancement devices (MADs) is rising.
- Additionally, sedentary lifestyles, poor diets, and high alcohol and tobacco consumption are contributing to rising obesity rates, which are closely linked to snoring. A survey by C3 Collaborating for Health shows that one in six adults in France is obese, highlighting a significant health concern.
Between 2025 and 2034, the Asia Pacific anti-snoring treatment market is anticipated to grow significantly.
- Several factors are driving the growth of the market in the Asia Pacific. Increasing awareness of sleep disorders and their health impacts has boosted demand for effective solutions. Rising obesity rates and sleep apnea, particularly among the aging population, are also creating significant market opportunities.
- Technological advancements in anti-snoring devices have expanded the range of options available to consumers. At the same time, rising disposable incomes in many Asia Pacific countries have increased healthcare spending, including on sleep-related treatments like sleep apnea devices, further driving market growth.
From 2025 to 2034, South Africa's market is expected to grow significantly.
- In South Africa, rising obesity rates are a key factor driving the growth of the anti-snoring treatment market.
- Excess weight is a known risk factor for snoring, as it can narrow airways during sleep. As obesity rates increase, more individuals are seeking anti-snoring treatments, boosting market growth. According to the Human Sciences Research Council, about 50% of adults in South Africa are overweight or obese, indicating a large potential market for anti-snoring devices.
- Additionally, the prevalence of respiratory diseases in South Africa has increased awareness and demand for anti-snoring solutions, as people look to improve respiratory health and reduce sleep disruptions caused by snoring.
- These factors are expected to drive the growth of South Africa's market in the coming years.